Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6767 (MIR6767)
- Target
- MIR6767
- Molecular classification
- MicroRNA (miRNA), Small non-coding RNA, No recognized receptor, enzyme, transporter, or protein family associations
01
Overview
MicroRNA 6767 (MIR6767) is a human microRNA encoding a small non-coding RNA involved in post-transcriptional regulation of gene expression. The mature form, miRNA-6767-5p, has been identified as a possible biomarker in polycystic ovary syndrome, associated with immune response regulation, cell cycle modulation, and metabolic functions. However, there are no established roles for MIR6767 in major diseases, no recognized interacting drugs, and it is not considered a canonical therapeutic target. The lack of significant molecular or functional characterization and sparse biomedical literature indicate that this target may be poorly defined, under-characterized, or possibly misrepresented in some contexts[1][4][6].
- Other names
- hsa-mir-6767miRNA-6767-5pmicroRNA mir-6767
02
Mechanism of action
General miRNA mechanism: binds to complementary mRNA, represses translation, or induces degradation. No recognized drugs exploit MIR6767 for therapeutic effect.
03
Biological functions
Regulation of immune system genesCell cycle modulationPossible endocrine/metabolic roles in reproductive tissueOverall miRNAs regulate post-transcriptional gene silencing and diverse processes, but only indirect evidence exists for this specific miRNA
04
Disease associations
Polycystic ovary syndrome (PCOS)No established roles in cancer, inflammation, neurodegeneration, or other common miRNA-linked diseases.
05
Safety considerations
None reported. General challenges for miRNA therapies include off-target effects and tissue specificity, but these do not apply to MIR6767 due to lack of direct therapeutic application.
06
Biomarkers
miRNA-6767-5p suggested as potential diagnostic biomarker for PCOS (lowered serum levels)No broader evidence for use as a clinical biomarker.
Beyond the preview
Go deeper on MicroRNA 6767 (MIR6767).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroRNA 6767 (MIR6767).